IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.
About IPO Scanner
IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.
Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.
Details of client bank account
For any query / feedback / clarifications, email at
[email protected].
Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.
© 2026 IPO Scanner. All rights reserved.

Issue Size
$75.00M
Price Range
$10.00
Shares
9.1M o/s · 7.5M offered
Listing Price
$10.00
Sector
Financials
Filed
Jun 08, 2026
Research Alliance Corporation IV
Research Alliance Corporation IV is a newly organized blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
We intend to focus on industries that complement our management team’s background, and to capitalize on the ability of our management team to identify and acquire a business, focusing on the healthcare or healthcare-related industries.
In particular, we are targeting companies in the drug development and commercialization, diagnostic and healthcare technology and service sectors where our management has extensive investment experience.
Ticker, listing venue and issuer profile
Pricing terms and IPO milestones
Key valuation ratios and metrics
Historical financial performance
Financial data is not available yet for this IPO.
Official documents from SEC EDGAR
| Form | Filing Date | Document |
|---|---|---|
| S-1 | Jun 8, 2026 | General form for registration of securities under the Securities Act of 1933 |
Contact and headquarters details
Key executives and officers
Matthew Hammond, Ph.D.
Chief Executive Officer and Director
Henry Stusnick
Chief Business Officer and Chief Operating Officer
Fran Adams
Chief Financial Officer